Beranda › Dermatitis Atopik (Eksim) › Arizona
Uji klinis Dermatitis Atopik (Eksim) di Arizona
7 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi di Arizona.
Kota di Arizona
Teks studi resmi (Bahasa Inggris)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- San Tan Allergy & Asthma- Site Number : 8400031, Gilbert
- Saguaro Dermatology- Site Number : 8400028, Phoenix
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07290803A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Mayo Clinic Hospital, Phoenix
- Mayo Clinic Specialty Building, Phoenix
- Mayo Clinic, Scottsdale
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07216027Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- U.S. Dermatology Partners, Phoenix
Menerima pesertaStudi observasional
Usia 12 hingga 89 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07645820A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Saguaro Dermatology Associates, Phoenix
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599813A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- One Of A Kind Clinical Research Center - Scottsdale /ID# 278675, Scottsdale
Menerima pesertaFase 3
Usia 18 hingga 63 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Onyx Clinical Research - Peoria, Peoria
- Medical Dermatology Specialists, Phoenix
- Onyx Clinical Research, Phoenix
- dan 1 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galdrma Investigational Site - 7077, Phoenix
- Galderma Investigational Site 7060, Phoenix
- Galderma Investigational Site - 8535, Phoenix
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06988605Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.